Asymchem Laboratories, a leading contract development and manufacturing organisation (CDMO), is headquartered in China (CN) and operates extensively across Asia and North America. Founded in 1997, Asymchem has established itself in the pharmaceutical and biotechnology sectors, specialising in the development and production of active pharmaceutical ingredients (APIs) and intermediates. With a commitment to innovation, Asymchem offers a comprehensive range of services, including process development, scale-up, and commercial manufacturing. Their unique approach combines advanced technology with a strong emphasis on quality, ensuring that clients receive tailored solutions that meet stringent regulatory standards. Recognised for its market leadership, Asymchem has achieved significant milestones, including successful collaborations with major pharmaceutical companies and a robust portfolio of proprietary technologies. This positions Asymchem as a trusted partner in the global pharmaceutical landscape.
How does Asymchem Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Asymchem Laboratories's score of 44 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Asymchem Laboratories reported total greenhouse gas emissions of approximately 237,185,310 kg CO2e, comprising about 46,854,490 kg CO2e from Scope 1 and about 190,330,820 kg CO2e from Scope 2 emissions. This represents a slight decrease from 2022, where total emissions were about 240,472,280 kg CO2e, with Scope 1 emissions at approximately 76,747,780 kg CO2e and Scope 2 emissions at about 163,724,500 kg CO2e. Asymchem has set ambitious climate commitments, aiming to reduce absolute greenhouse gas emissions from both Scope 1 and Scope 2 by 10% by 2030, using 2022 as the baseline year. This initiative reflects the company's commitment to sustainability and aligns with industry standards for climate action. The reduction targets specifically focus on their small molecule CDMO business, indicating a strategic approach to managing emissions in key operational areas. Overall, Asymchem Laboratories is actively working towards minimising its carbon footprint while maintaining transparency in its emissions reporting and reduction strategies.
Access structured emissions data, company-specific emission factors, and source documents
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Scope 1 | 34,013,280 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 98,843,870 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Asymchem Laboratories is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.